Evidence map›Paper›PMID 23742070›Full record

ArticleBMC bioinformatics2013

Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis.

Florent Baty, Jochen Rüdiger, Nicola Miglino, Lukas Kern, Peter Borger, Martin Brutsche

Abstract read
In one paragraph

Article in BMC bioinformatics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florent BatyDivision of Pulmonary Medicine, Cantonal Hospital St, Gallen, Rorschacherstrasse 95, CH-9007 St, Gallen, Switzerland. florent.baty@kssg.ch
Jochen Rüdiger
Nicola Miglino
Lukas Kern
Peter Borger
Martin Brutsche

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInterpretation of gene expression microarray data in the light of external information on both columns and rows (experimental variables and gene annotations) facilitates the extraction of pertinent information hidden in these complex data. Biologists classically interpret genes of interest after retrieving functional information from a subset of genes of interest. Transcription factors play an important role in orchestrating the regulation of gene expression. Their activity can be deduced by examining the presence of putative transcription factors binding sites in the gene promoter regions.

resultsIn this paper we present the multivariate statistical method RLQ which aims to analyze microarray data where additional information is available on both genes and samples. As an illustrative example, we applied RLQ methodology to analyze transcription factor activity associated with the time-course effect of steroids on the growth of primary human lung fibroblasts. RLQ could successfully predict transcription factor activity, and could integrate various other sources of external information in the main frame of the analysis. The approach was validated by means of alternative statistical methods and biological validation.

conclusionsRLQ provides an efficient way of extracting and visualizing structures present in a gene expression dataset by directly modeling the link between experimental variables and gene annotations.

Indexed as

Binding SitesCell ProliferationFibroblastsGene Expression ProfilingHumansLungMolecular Sequence AnnotationMometasone FuroateMultivariate AnalysisOligonucleotide Array Sequence AnalysisPregnadienediolsTranscription FactorsMometasone FuroatePregnadienediolsTranscription Factors

Identifiers

PMID23742070
PMCPMC3686578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.